Through
10/10
Immunology
Two Penn faculty elected to the American Philosophical Society
Two Penn faculty elected to the American Philosophical Society
Paul Offit and Dorothy Roberts have been recognized for extraordinary accomplishments in their fields.
The path from innovation to implementation
The path from innovation to implementation
Penn’s infrastructure in both supporting clinical research and forging commercial partnerships smooths the way from idea to approval.
Improved gene editing method could power future cell and gene therapies
Improved gene editing method could power future cell and gene therapies
A new technique based on special cell-penetrating peptides promises advantages over current methods for editing the genomes of primary cells, such as patients’ T cells.
Why Penn research powers many FDA-approved treatments
Why Penn research powers many FDA-approved treatments
Since 2017, the FDA approved more than two dozen new therapies with roots at Penn Medicine—almost half of which are first-in-class for their indications.
A potential strategy to improve T cell therapy in solid tumors
A potential strategy to improve T cell therapy in solid tumors
A new Penn Medicine preclinical study finds that a new simultaneous “knockout” of two inflammatory regulators boosted T cell expansion to attach solid tumors.
Harnessing an innate protection against Ebola
Harnessing an innate protection against Ebola
School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals.
Five things to know about this year’s ‘tripledemic’
Five things to know about this year’s ‘tripledemic’
The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding.
CAR T cell therapy may eliminate tumor cells missed by surgery
CAR T cell therapy may eliminate tumor cells missed by surgery
The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.
Advances in cancer research
Advances in cancer research
Recent research shows promise in a novel CAR T therapy after cancer relapse, and a novel treatment for multiple myeloma.
CAR T cell therapy reaches beyond cancer
CAR T cell therapy reaches beyond cancer
Penn Medicine researchers laud the early results for CAR T therapy in lupus patients, which point to broader horizons for the use of personalized cellular therapies.
In the News
Philadelphia Business Journal
Philadelphia life sciences jobs being filled more by women than men, study finds
Jean Bennett, Katalin Karikó, and Drew Weissman of the Perelman School of Medicine are noted for their advancements in gene therapy and mRNA technology.
FULL STORY →
USA Today
In what could be a ‘big shift’ for cancer treatment, mRNA vaccine shows promise against melanoma
According to Robert Vonderheide of the Perelman School of Medicine, the pandemic proved that mRNA vaccines could be used safely and developed quickly.
FULL STORY →
The Wall Street Journal
Moderna, Merck show progress toward cancer vaccines
Robert Vonderheide of the Perelman School of Medicine says that a combined immunotherapy-vaccine approach could be a game changer for melanoma patients.
FULL STORY →
Associated Press
Novel treatment shows promise against rare cancer in kids
Carl June of the Perelman School of Medicine comments on the success of a new study using CAR-T cell therapy to combat tumors in children with a rare kind of cancer.
FULL STORY →
The Hill
Could the silver lining of the pandemic be pan-vaccines?
Scott Hensley of the Perelman School of Medicine and colleagues have developed a vaccine that could provide a baseline level of protection against all 20 known flu strains.
FULL STORY →
The Atlantic
The next stage of COVID is starting now
Scott Hensley of the Perelman School of Medicine says that children’s responses and vulnerability to future bouts of coronavirus may depend on the variants they encounter.
FULL STORY →